Login

We are 40! Talks at DFI - Steven Tsai, President of DFI Inc | Steven Tsai, CEO, DFI Inc2397:TAI 00:10:00

Share On Facebook Share On Twitter

Currently, Steven Tsai is the President of DFI Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Strategic Outlook: Economic Trends and Investment Insights with Alex Shivananda | Alex Shivananda, Managing Director, Cambridge Associates LLC.
00:10:00
ACG Metals CEO Artem Volynets Announces $290 Million Acquisition of Gediktepe Mine | Artem Volynets, CEO , ACG Acquisition Company Ltd.
00:10:00
A major player in private equity and infrastructure|Andrew Lockhart,Partner, Metrics Credit Partners
00:10:00
"Global Perspectives on Investment Opportunities: Equity, Fixed Income, and Multi-Asset Strategies with Janus Henderson's Jeremiah Buckley and Greg Wilensky"
00:10:00
Jim Russo on American Resilience and Staying Invested Through Challenges | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
BVZ Holding CEO Fernando Lehner on H1 2022, Future Projects, and Motivating His Team Amidst Challenges | Fernando Lehner - CEO of bvz holding ag
00:10:00
American Lithium's Strategic Expansion and Key Milestones: Insights from CEO Simon Clark
00:10:00
Our Approach to Real Estate Investing: Insights from Brad Morrissey and Brian Butt of Johnson Investment Counsel
00:00:00
Interview of Alexandre Fraichard, CEO of Genoway
00:10:00
Mastering Financial Planning Interviews: Key Qualities and Strategies
00:10:00
Bradesco's Strategic Evolution: Navigating Challenges and Transforming Retail Banking | Marcelo Noronha, CEO, Banco Bradesco S.A.
00:10:00
Specialized in strategy and organization|Rolando Quintas,Senior Manager,Pericles Capital Partners

© 2017 - Neuhu+